Pharma The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have returned to robust levels with 550+ trials in total in 2013 and 250+ important Phase I and II trials. Click here to read more articles and…
Pharma The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export growth. Click here to read more articles and interviews from Italy, and to download the latest free pharma report on the country.
Pharma Professor Dr. Susan M. Gasser of the Friedrich Miescher Institute for Biomedical Research describes FMI’s fundamental connection between academia and industry in Switzerland, the effects of the foundation’s research, notably on Novartis, and future projects in the making. Could you begin by introducing both yourself and your institute to our…
Pharma Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active rheumatoid arthritis, building upon Pfizer’s tradition of developing patient-centered therapies. She also discusses supporting research in Switzerland through the Pfizer Research Prize Foundation, which celebrates its 25th anniversary in 2016. What have…
PPP Known as “Ireland’s university of Enterprise,” Dublin City University’s research and educational philosophy is very much informed by the institution’s strong partnerships and collaborations with the private sector. Professor Brian MacCraith discusses the institutions’ unique approach to academic-private collaborations and some of the initiatives currently underway in the life science…
Pharma Founded in 2011, APC has grown to be the largest process development company in Ireland. It is the largest employer of PhD Chemical Engineers nationally, is partners with the largest pharma and biotech companies globally, and over 80% of the company’s revenue is export driven. Since starting APC in 2011, what have been…
Health In the year of Gen Suisse’s 25th anniversary, CEO Daniela Suter talks supporting dialogue between scientists and politicians on life sciences in Switzerland, educating the general population, the attractiveness of the Swiss community for scientists, and her goals for the future. Could you give our international viewers an overview of…
Pharma Reckitt Benckiser’s General Manager for the CEE region, Lajos Magyari, discusses the strength of the company’s current portfolio, the importance of innovation and the success factors he focuses on to drive growth in the region. He outlines the company’s vision for 2020 and the significance of the health category segment.…
R&D Professor Dr. Robert Riener speaks about the much anticipated Cybathlon event and its importance to technology transfer, the Swiss education system’s ability to attract international talent, and his goals for the future. You have been leading the Department of Health Sciences and Technology at ETH Zurich since February 2016. Could…
Pharma The executive director of the French Chamber of Commerce and Industry (FCCI) in Singapore, Carine Lespayandel pinpoints the key facets of the Singaporean economy that have captivated the continued interests of French companies, while highlighting the chamber’s fundamental role in facilitating investment growth between the two countries moving forward. What…
Pharma Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low cost labor like many of its Asian neighbors and pivoting into a more knowledge-based and innovation-intensive economy. Chemicals, engineering, and electronics have always served as key manufacturing segments, but only starting from…
See our Cookie Privacy Policy Here